Yoshida E, Sumi H, Tsushima H, Maruyama M, Mihara H
Department of Physiology, Miyazaki Medical College, Japan.
Inflammation. 1991 Feb;15(1):71-9. doi: 10.1007/BF00917911.
Inter-alpha-trypsin inhibitor (ITI) is a complex that consists of three components. One of these is the acid-stable proteinase inhibitor (ASPI), which is an acute-phase reactant and a broad-spectrum inhibitor. The tissue distribution of ITI and ASPI were investigated and compared using immunohistochemical methods. ITI immunoreactivity was revealed only in the liver and plasma, while ASPI immunoreactivity was found to be distributed in the brain, liver, kidney, gastrointestinal tract, plasma, and urine. Both immunoreactivities were demonstrated in Kupffer cells of the liver, which is thought to be an ITI-producing organ. From these results, it seems unlikely that ASPI is distributed as a part of the ITI molecule. The residual component of ITI may act as a carrier protein of ASPI, or ASPI in the tissues may be produced independently of ITI.
α-胰蛋白酶抑制剂(ITI)是一种由三个成分组成的复合物。其中之一是酸稳定蛋白酶抑制剂(ASPI),它是一种急性期反应物和广谱抑制剂。采用免疫组化方法研究并比较了ITI和ASPI的组织分布。ITI免疫反应仅在肝脏和血浆中显示,而ASPI免疫反应则分布于脑、肝、肾、胃肠道、血浆和尿液中。在肝脏的库普弗细胞中均证实了这两种免疫反应,肝脏被认为是产生ITI的器官。从这些结果来看,ASPI作为ITI分子的一部分进行分布似乎不太可能。ITI的残余成分可能作为ASPI的载体蛋白,或者组织中的ASPI可能独立于ITI产生。